Granulocytic sarcoma presenting with severe adenopathy (cervical lymph nodes, tonsils, and adenoids) in a child with juvenile myelomonocytic leukemia and successful treatment with allogeneic bone marrow transplantation

International Journal of Hematology

Volumn 80, Issue 2, 2004, Pages 186-189

  Imamura, Toshihiko ^a   Matsuo, Satoshi ^b   Yoshihara, Takao ^a   Chiyonobu, Tomohiro ^a   Mori, Kanako ^a   Ishida, Hiroyuki ^a   Nishimura, Yasutaka ^a   Kasubuchi, Yasuo ^a   Naya, Mayumi ^c   Morimoto, Akira ^d   Hibi, Shigeyoshi ^d   Imashuku, Shinsaku ^c,e  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^c KYOTO CITY HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e Kyoto City Institute of Health and Environmental Sciences   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Granulocytic sarcoma; Juvenile myelomonocytic leukemia; Myelodysplastic syndrome

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TACROLIMUS; VINCRISTINE;

ADENOID; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 9; CLINICAL FEATURE; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTIC SARCOMA; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKEMIA REMISSION; LYMPHADENOPATHY; MYELOID LEUKEMIA; SCHOOL CHILD; TONSIL; WHOLE BODY RADIATION;

ADENOIDS; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPH NODES; SARCOMA, GRANULOCYTIC; TONSIL; TREATMENT OUTCOME;

EID: 4444362095     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04040     Document Type: Article

References (21)

1. Byrd JC, Edenfield WJ, Down NS, Aylesworth C, Dawson N. Extramedullary myeloid cell tumors in myelodysplastic syndromes: not a true indication of impending acute myeloid leukemia. Leuk Lymphoma. 1996;21:153-159.
2. Hicsonmez G, Cetin M, Yenicesu I, et al. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptoms. Leuk Lymphoma. 2001;42:665-674.
3. Reinhardt D, Creutzig U. Isolated myelosarcoma in children: update and review. Leuk Lymphoma. 2002;43:565-574.
4. Colle I, Lacor L, Peelers P, Jochmans K, De Raeve H, Van Camp B. Granulocytic sarcoma (chloroma): a report of two cases. Acta Clin Belg. 1996;51:106-110.
5. Geisse M, Mall G, Fritze D, Gartenschlager M. Granulocytic sarcoma of the tonsils associated with myelodysplastic syndrome. Dtsch Med Wochenschr. 2002;127:2673-2676.
6. Kojima M, Nakamura S, Shimizu K, Yamane Y, Itoh H, Masawa N. Granulocytic sarcoma presenting with lymph node infarction at disease onset. APMIS. 2003;111:1133-1136.
7. Arico M, Biondi A, Pui C-H. Juvenile myelomonocytic leukemia. Blood. 1997;90:479-488.
8. Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the children's cancer group. J Clin Oncol. 2002;20:434-440.
9. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease. Leukemia. 2003;17:277-282.
10. Niemeyer CM, Arico M, Basso A, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997;89:3534-3543.
11. Locatelli F, Niemeyer C, Angelucci E, et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol. 1997;15:566-573.
12. Tuncer AM, Pagulucia A, Hicsonmez G, Yetgin S, Ozsoylu S, Mufti GJ. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases. Br J Haematol 1992;82:347-353.
13. Hicsonmez G, Tuncer AM, Sayli T, et al. High-dose methylprednisolone, low dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes. Hematol Pathol. 1995;9:185-193.
14. Anderson JF, Appelbaum FR, Schoch G, et al. Allogeneic bone marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. J Clin Oncol. 1996;14:220-226.
15. Hasle H. Myelodysplastic syndromes in childhood: classification, epidemiology, and treatment. Leuk Lymphoma. 1994;13:11-26.
16. Sasaki H, Manabe A, Kojima S, et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia. 2001;15:1713-1720.
17. Pinkel D. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood. 1998;91:365-367.
18. Pui CH, Arico M. Isotretinoin for juvenile chronic myelomonocytic leukemia. N Engl J Med. 1995;332:1520-1521.
19. Passmore SJ, Hann IM, Stiller CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood. 1995;85:1742-1750.
20. Ratanatharathorn V, Karanes C, Uberti J, et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood. 1993;81:2194-2199.
21. Manabe A, Okamura J, Yumura-Yagi K, et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia. 2002;16:645-649.